Skip to main content
Joseph Palumbo, MD, Pediatric Hematology & Oncology, Cincinnati, OH

JosephSPalumboMD

Pediatric Hematology & Oncology Cincinnati, OH

Pediatric Coagulation Disorder Hematology

Associate Professor, Pediatrics, University of Cincinnati College of Medicine

Dr. Palumbo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Palumbo's full profile

Already have an account?

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1993 - 1996
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 1993

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1996 - 2026
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • Intermediate Term Thrombotic Risk in Contemporary Total Cavo-Pulmonary Connection for Single Ventricle Circulations  
    Jenna M Faircloth, Tarek Alsaied, Gruschen R Veldtman, Joseph S Palumbo, Journal of Thrombosis and Thrombolysis

Abstracts/Posters

  • Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth
    Joseph S. Palumbo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Pediatric Patient with Hypodysfibrinogenemia Presenting with an Unprovoked Portal Vein Thrombosis
    Joseph S. Palumbo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Inflammation and Tissue Damage Mediated By PAR-1 Expression Is Cell Type-Specific and Varies Depending on the Inflammatory Challenge 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Grant Support

  • Mechanisms Linking Metastasis To Tumor Procoagulant And Innate ImmunityNational Heart, Lung, And Blood Institute2010
  • Mechanisms Linking Metastasis To Tumor Procoagulant And Innate ImmunityNational Heart, Lung, And Blood Institute2006–2009
  • Hemostatic Factors And Tumor BiologyNational Heart, Lung, And Blood Institute2003–2007
  • Role Of Hemostatic Factors In Tumor BiologyNational Cancer Institute2001–2002